Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Crombez Eric sold 344 Ultragenyx Pharmaceutical Inc. shares (Form 4)
Traded May 5, 2026 · Filed May 6, 2026
On May 5, 2026, Crombez Eric (EVP and Chief Medical Officer) sold 344 Ultragenyx Pharmaceutical Inc. shares at US$24.96 for US$8,586, leaving 111,189 shares. Filed May 6, 2026 (Form 4).
- Sold
- 344 shares
- Price
- US$24.96
- Value
- US$8,586
- Holding after
- 111,189 shares
- Trading plan
- No
- Role
- EVP and Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Sale | 344 | US$24.96 | 111,189 | Direct |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Crombez Eric
- Ultragenyx Pharmaceutical Inc. shareholders
- Form 4 · Crombez Eric · Apr 20, 2026
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026